Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)

  • Technology appraisal
  • TA750
  • Published: 

History

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators